ResearchMoz

Global Dialysis Market Report: 2012 Edition

Koncept Analytics
Published Date » 2012-09-01
No. Of Pages » 48
   
 With the fast pace evolution of technology, economy, lifestyle and every other aspect of the surrounding environment, the most affected part of our lives is the health and the vital organs of body are the ones who bear the brunt. Uncertain lifestyle, bad eating habits are few such factors which are giving rise to numerous health related issues like diabetes, obesity, hypertension etc. All these underlying conditions in turn put key organs like heart and kidneys at risk. 
   
 The slow progression in the kidney functioning (reduced GFR) is termed as Chronic kidney disease (CKD). As per the severity of the disease, CKD is bifurcated in 5 stages, the fifth being the most severe, in which the complete impairment of kidneys/total loss of kidney function takes place. This stage is...
Table of Content

1. Dialysis: An Overview
1.1 Chronic Kidney Disease (CKD)
Key Facts
Stages of CKD
Disease Progression & Management
1.1.1 End Stage Renal Disease (ESRD)
1.2 Dialysis
Hemodialysis
Peritoneal Dialysis

2. Dialysis Market: An Analysis
2.1 Global Dialysis Patient Population
ESRD Patients Growth
Regional Breakdown
2.2 Global Dialysis Market
Market Value
Market Segments
  • Products Market
  • Services Market 
2.3 Dialysis Market by Geography
North America
Europe
Asia Pacific
Latin America

3. Market Dynamics
3.1 Key Trends
3.1.1 Introduction of Bundled Reimbursement Model
3.1.2 Preference for Peritoneal Dialysis over Hemodialysis
3.1.3 Inclination towards Nocturnal Dialysis
3.1.4 Cost Variation: Average HHD Cost per Treatment Lower than In-Center HD
3.1.5 Distribution of Dialysis Clinics by Ownership
3.2 Growth Drivers
3.2.1 Growing Number of Diabetic Patients Worldwide
3.2.2 Expanding Obese Population
3.2.3 Increasing Cases of Hypertension
3.2.4 Growing Adult Population Worldwide
3.2.5 Illicit Consumption of Non-prescription Drugs
3.2.6 Increasing Expenditure on Healthcare
3.2.7 Increasing Global GNI (Gross National Income)
3.3 Challenges
3.3.1 Associated Risks and after-Effects of the Treatment
3.3.2 High Treatment Costs

4. Dialysis Market - Competitive Landscape
Market Overview
Overall Market Share
Segment Share
No. of Patients Treated

5. Company Profiles
5.1 DaVita Inc.
Business Overview
Financial Overview
Business Strategies
Development through Strategic Partnerships
Growth through Companys Core Values
5.2 Baxter International Inc.
Business Overview
Financial Overview
Business Strategies
Investment in Research & Development
Growth through Sustainable Development
5.3 Fresenius Medical Care
Business Overview
Financial Overview
Business Strategies
Sustainable Growth Strategy
Strategic Investments

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables


Risk Factors for CKD
Stages of CKD
Renoprotective Strategies for Slowing Progression of CKD
Advantages and Disadvantages of Dialysis Methods
Dialysis Patients Regional Development (2011)
Average Cost Comparison for Hemodialysis Treatment
Market Position in Major Product Groups (2011)
Number of Patients Treated by Region (2011)
Dependent & Independent Variables (20072011)
Correlation Matrix
Model Summary Coefficient of Determination
Regression Coefficients Output

List of Figures


eGFR across the Stages of CKD
Regional Distribution of ESRD Patient Treatments (2011)
Global Share of ESRD Treatment Procedures (2007-2011)
Dialysis Patient Population Worldwide (2005-2015E)
Dialysis Patient Population Share by Region (2011)
Global Dialysis Market (2010-2011)
Global Dialysis Market Bifurcation by Segments (2011)
Global Dialysis Product Market (2006-2011)
Global Dialysis Services Market (2006-2011)
Global Dialysis Market Share by Geography (2010)
Global Dialysis Market Share by Geography (2015E)
Asia Pacific Dialysis Market (2000 & 2010)
North America Dialysis Market (2000 & 2010)
Latin America Dialysis Market (2000 & 2010)
Europe Dialysis Market (2000 & 2010)
Global Reimbursement for Dialysis Services (2000 & 2015E)
Worldwide ownership of the Dialysis Centers (2011)
Regional Ownership of the Dialysis Centers (2011)
Global Diabetes Population (2006-2011)
Causes of ESRD in the US (2011)
Recent Status and Outlook for Global Diabetic Patients (2010-2030)
Global Prevalence Rate of Diabetes by Age Group (2010)
Growth in Worldwide Obese Population (2004-2012F)
BP Pattern across various Stages of Hypertension
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
Rising Global Adult Population (2007-2012E)
World Gross National Income (2005-2010)
Dialysis Product Market Share (2011) 
Dialyzers Market Share (2011)
Dialysis Machines Market Share (2011)
Hemodialysis Products Market Share (2011)
Peritoneal Dialysis Products Market Share (2011)
Top 5 Dialysis Services Providers Worldwide (2011)
DaVita Inc. Revenue Share by Business Segments (2011)
DaVita Inc. Revenue and Net Income Analysis (2008-2011)
Baxters Revenue by Business Segments (2011)
Baxters Revenues and Net Income (2008-2011)
Fresenius Medical Care Revenue Share by Business Segments (2011)
Fresenius Medical Care Revenue and net Income Analysis (2008-2011)
Global Dialysis Market Forecast (2007-2014F)

Upcoming Reports:

Cardiac Pacemakers Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The global market for cardiac pacemakers is forecasted to reach the market value of $5.1 billion at the compounded annual growth rate of 11% during the forecasted period. North America is the largest market for cardiac pace-makers accounting for nearly 40% of the total market share followed by Europe accounting for about 30% of the total market. Asia Pacific, although not largest, but is the fastest growing region with compounded annual growth rate of 13.3%.  As the population continues to grow, there is an increase in the number of elderly population. There are...
Image Guided Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
By - Transparency Market Research
Image guided surgery makes use of preoperative images to precisely guide surgical instruments by correlating the operative field. The image guidance systems also help in seamless procedure planning, thus reducing chances of error and also minimizing procedure time. With image guided systems, overall productivity is increased and being minimally invasive, allows quick recovery and shorter hospital stay. The technique was initially developed for neurosurgeries, which is one of the most critical procedures. ENT surgeries still remain the main area of application of image guided...
Ultrasound Sensors Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
The increasing number of applications in healthcare such as Renal Denervation and Sonography along with the miniaturization of these devices particularly for minimally invasive procedures is predicted to drive the market for these sensors in the coming years. Other drivers are the non-invasive procedures performed by HIFU or High Intensity Focused Ultrasound devices which may not even require contact of the device. Acceptance in medical community particularly with regards to safety and efficacy of ultrasound is expected to be a significant driver for these sensors in the coming years....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...